Wuxi Boton Technology Co., Ltd. (300031.SZ)
CNY 22.99
(1.95%)
CNY 22.99
(1.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.65 Billion | 3.25 Billion | 2.75 Billion | 2.63 Billion | 2.47 Billion | 2.16 Billion |
| Cost of Revenue | 2.21 Billion | 1.97 Billion | 1.62 Billion | 1.56 Billion | 1.02 Billion | 983.34 Million |
| Gross Profit | 1.43 Billion | 1.28 Billion | 1.13 Billion | 1.07 Billion | 1.45 Billion | 1.18 Billion |
| Operating Expenses | 1.31 Billion | 1.25 Billion | 828.39 Million | 751.04 Million | 1.11 Billion | 839.35 Million |
| Selling, General and Administrative Expenses | 806.53 Million | 887.64 Million | 563.23 Million | 545.92 Million | 958.77 Million | 712.36 Million |
| Research and Development Expenses | 137.84 Million | 158.88 Million | 134.46 Million | 72.82 Million | 51.17 Million | 36.41 Million |
| Other Expenses | 106.94 Million | 208.49 Million | 130.69 Million | 132.28 Million | 102.29 Million | -847.95 Thousand |
| Cost and Expenses | 3.54 Billion | 3.22 Billion | 2.45 Billion | 2.31 Billion | 2.13 Billion | 1.82 Billion |
| Operating Income | 113.76 Million | 159.73 Million | 446.34 Million | 521.81 Million | 311.27 Million | 311.24 Million |
| Interest Expense | 24.02 Million | 21.35 Million | 21.88 Million | 24.98 Million | 27.44 Million | 15.35 Million |
| Income Tax Expense | 1.83 Million | 46.5 Million | 60.49 Million | 79.76 Million | 24.99 Million | 21.39 Million |
| Earnings before Tax | 112.83 Million | -422.13 Million | 443.88 Million | 520.78 Million | 311.41 Million | 310.39 Million |
| Net Income | 106.06 Million | -468.63 Million | 402.66 Million | 436.76 Million | 305.04 Million | 271.74 Million |
| Earnings Per Share Basic | 0.26 | -1.14 | 0.98 | 1.13 | 0.79 | 0.69 |
| Earnings Per Share Diluted | 0.25 | -1.14 | 0.98 | 1.13 | 0.79 | 0.69 |
| Weighted Average Shares Outstanding | 412.37 Million | 411.88 Million | 411.73 Million | 385.1 Million | 385.1 Million | 392.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.73 Million | 411.88 Million | 411.73 Million | 385.1 Million | 385.1 Million | 392.52 Million |
| Gross Margin | 0.39 | 0.40 | 0.41 | 0.41 | 0.59 | 0.55 |
| EBIT Margin | 0.07 | 0.05 | 0.19 | 0.23 | 0.16 | 0.17 |
| Profit Margin | 0.03 | -0.14 | 0.15 | 0.17 | 0.12 | 0.13 |
| EBITDA | 253.87 Million | 169.19 Million | 557.6 Million | 654.58 Million | 374.44 Million | 376.21 Million |
| Earnings Before Tax Margin | 0.03 | 0.05 | 0.16 | 0.20 | 0.13 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 732.25 Million | 873.49 Million | 839.46 Million | 1.23 Billion | 3.65 Billion | 872.59 Million |
| Cost of Revenue | 467.96 Million | 533.77 Million | 463.5 Million | 721.85 Million | 2.21 Billion | 529.65 Million |
| Gross Profit | 264.29 Million | 339.71 Million | 375.95 Million | 515.65 Million | 1.43 Billion | 342.93 Million |
| Operating Expenses | 184.1 Million | 229.6 Million | 245.86 Million | 404.31 Million | 1.18 Billion | 336.53 Million |
| Selling, General and Administrative Expenses | 331.45 Million | 169.5 Million | 215.71 Million | 111.35 Million | - | 426.66 Million |
| Research and Development Expenses | 30.74 Million | 46.29 Million | 28.09 Million | 50.48 Million | - | 29.08 Million |
| Other Expenses | -178.1 Million | -13.8 Million | 26.32 Thousand | -84.45 Million | -86.64 Million | -45.78 Million |
| Cost and Expenses | 652.06 Million | 763.37 Million | 709.37 Million | 1.12 Billion | 3.4 Billion | 866.19 Million |
| Operating Income | 53.46 Million | 110.11 Million | 115.17 Million | -46.64 Million | 113.76 Million | -11.45 Million |
| Interest Expense | 4.89 Million | 6.07 Million | 4.44 Million | 5.11 Million | 20.23 Million | 5.8 Million |
| Income Tax Expense | -4.86 Million | 4.47 Million | 3.69 Million | -20.31 Million | 1.83 Million | 3.31 Million |
| Earnings before Tax | 52 Million | 118.21 Million | 115.19 Million | -45.4 Million | 112.83 Million | -11.99 Million |
| Net Income | 46.97 Million | 104.85 Million | 85.86 Million | 2.64 Million | 106.06 Million | -18.48 Million |
| Earnings Per Share Basic | 0.11 | 0.25 | 0.21 | 0.01 | - | -0.04 |
| Earnings Per Share Diluted | 0.11 | 0.25 | 0.21 | 0.01 | - | -0.04 |
| Weighted Average Shares Outstanding | 412.52 Million | 412.52 Million | 412.8 Million | 412.52 Million | 412.37 Million | 412.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 412.52 Million | 412.52 Million | 414.79 Million | 412.52 Million | 417.73 Million | 412.52 Million |
| Gross Margin | 0.36 | 0.39 | 0.45 | 0.42 | 0.39 | 0.39 |
| EBIT Margin | 0.08 | 0.18 | 0.16 | 0.03 | - | -0.05 |
| Profit Margin | 0.06 | 0.12 | 0.10 | 0.00 | 0.03 | -0.02 |
| EBITDA | 56.9 Million | 153.38 Million | 133.81 Million | 35.41 Million | - | -39.83 Million |
| Earnings Before Tax Margin | 0.07 | 0.13 | 0.14 | -0.04 | 0.03 | -0.01 |
301190
SGRO
300684
0SAY
KOHINOOR
KLINIQ